You have accessJournal of UrologyUrodynamics/Incontinence/Female Urology: Incontinence—Evaluation & Therapy1 Apr 20111342 EFFECT OF SACRAL NERVE MODULATION ON SENSORY PERCEPTION OF THE BLADDER, URETHRA AND PERINEUM Frank Burks, David Wenzler, Donna Carico, and Kenneth Peters Frank BurksFrank Burks Royal Oak, MI More articles by this author , David WenzlerDavid Wenzler Royal Oak, MI More articles by this author , Donna CaricoDonna Carico Royal Oak, MI More articles by this author , and Kenneth PetersKenneth Peters Royal Oak, MI More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2011.02.1163AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Sacral neuromodulation (SNM) is used to treat symptoms of overactive bladder (OAB) refractory to other therapies. SNM is theorized to alter the neural pathways in the spinal cord or brain that mediate bladder and urethral sensation and thereby treat the symptoms of OAB. We hypothesize that SNM affects bladder and urethral current perception thresholds (CPTs) of this sensory pathway. METHODS Ten women were enrolled in this IRB approved study of CPTs before and after SNM therapy. The mean age was 57 (31–73), with 9/10 women being post-menopausal. The Neurometer was used to measure CPTs at 5 Hz (C-fibers), 250 Hz (A-delta fibers), and 2000 Hz (A-beta fibers) on the right and left labia, perineum, urethra and bladder prior to and 1 month after SNM. Index finger readings at 2000 HZ served as controls as they should not be affected by SNM. A greater than 25% increase (less sensitive) in current perception threshold (CPT) is defined as a responder. RESULTS OAB questionnaire scores improved in all subjects. There was no change in CPT of the index finger as expected. Vulvar and perineal CPTs did not change significantly from pre-SNM to post-SNM. Nine of ten subjects agreed to have bladder and urethral CPT testing done. SNM had the greatest effect on the bladder and urethra at 250 Hz (A-delta) and 2000 Hz (A-beta). For the bladder CPTs, 5 of 9 of subjects at 250 Hz and 2000 Hz had at least a 25% increase in CPT (28% and 60% median positive change respectively). Minimal change was seen in the bladder and urethral CPTs at 5 Hz after SNM. The urethral CPT at 250 HZ was increased in 5 of 9 subjects with a median positive change of 43%. CPT testing was well tolerated with minimal adverse events. CONCLUSIONS This is the first attempt at measuring current perception thresholds before and after sacral neuromodulation. With a measurable change in CPT values for A-delta fibers (250Hz) and A-beta fibers (2000Hz), these findings suggest that SNM may modulate these large myelinated afferent fibers particularly in the bladder and urethra impacting the stimulus-response cycle contributing to OAB symptoms. More research is needed with a larger sample size to determine the actual significance of these findings. © 2011 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 185Issue 4SApril 2011Page: e536 Advertisement Copyright & Permissions© 2011 by American Urological Association Education and Research, Inc.MetricsAuthor Information Frank Burks Royal Oak, MI More articles by this author David Wenzler Royal Oak, MI More articles by this author Donna Carico Royal Oak, MI More articles by this author Kenneth Peters Royal Oak, MI More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...